Triple negative breast cancer
Conditions
Interventions
Sponsors
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Eligibility
Sex/Gender
Female
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patients who have undergone modified radical mastectomy or breast-conserving surgery for triple-negative breast cancer; 2. Aged 18 and 80 years; 3. have completed postoperative adjuvant chemotherapy and are on a first-line regimen (AT/TAC), and have not received chemotherapy or breast cancer-related medications within 1 month; 4. do not have significant cardiopulmonary or renal insufficiency; 5. Barthel Index score > 70.
Exclusion criteria
Exclusion criteria: 1. Combination of other malignant tumors, other autoimmune related diseases and endocrine diseases; 2. Patients with unclear pathological diagnosis or those who do not meet the staging of the group to which they belong; 3. Patients with significant cardiac, hepatic, renal, cerebral, neurological or hematopoietic dysfunction; 4. Women who are pregnant, lactating or preparing for pregnancy; 5. Patients with allergies or known hypersensitivity to therapeutic agents or components; 6. Patients with known distant metastases or recurrence; 7. Patients who are participating in other clinical drug trials; 8. Patients with a Barthel Index score <=60 on the daily living ability scale.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| blood test;Serum tumor markers;mtor; | — |
Countries
China
Contacts
Public ContactXiaoguang Shi
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Outcome results
None listed